Supplementary Figures S1-S5 from Alectinib Shows Potent Antitumor Activity against RET-Rearranged Non–Small Cell Lung Cancer

MLA

Hiroshi Sakamoto, et al. Supplementary Figures S1-S5 from Alectinib Shows Potent Antitumor Activity against RET-Rearranged Non–Small Cell Lung Cancer. Apr. 2023. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....07ee0f9f29687f483c70e880c01eb97d&authtype=sso&custid=ns315887.

APA

Hiroshi Sakamoto, Osamu Kondoh, Yoshiaki Watanabe, Miyuki Yoshida, Yasuko Satoh, Toshiyuki Tsukaguchi, & Tatsushi Kodama. (2023). Supplementary Figures S1-S5 from Alectinib Shows Potent Antitumor Activity against RET-Rearranged Non–Small Cell Lung Cancer.

Chicago

Hiroshi Sakamoto, Osamu Kondoh, Yoshiaki Watanabe, Miyuki Yoshida, Yasuko Satoh, Toshiyuki Tsukaguchi, and Tatsushi Kodama. 2023. “Supplementary Figures S1-S5 from Alectinib Shows Potent Antitumor Activity against RET-Rearranged Non–Small Cell Lung Cancer,” April. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....07ee0f9f29687f483c70e880c01eb97d&authtype=sso&custid=ns315887.